Greatbatch Acquires CCC Medical Devices; Advances Medical Device Strategy

FRISCO, Texas, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Greatbatch, Inc. (NYSE:GB) today announced that it has acquired CCC Medical Devices (CCC), the globally-respected active implantable medical device (AIMD) systems developer and manufacturer, effective immediately.

Based in Montevideo, Uruguay, CCC designs and produces a range of devices for some of the world's top medical device companies, including implantable pulse generators, programmer systems, battery chargers, patient wands and leads.

"Our acquisition of CCC is ideal by all accounts. It allows Greatbatch to more broadly partner with medical device companies, complements our core discrete technology offerings and enhances our medical device innovation efforts," said Thomas J. Hook, president and chief executive officer, Greatbatch. "Combining the knowledge, talent and customer base of both companies will produce better products for the medical community and better lives for people worldwide."

Financial terms of the transaction were not disclosed.

About Greatbatch, Inc.

Greatbatch, Inc. (NYSE:GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance. The company develops and manufactures critical medical device technologies for the cardiac, neuromodulation, vascular and orthopaedic markets; and batteries for high-end niche applications in the portable medical, energy, military, and environmental markets. Additional information is available at

Centro de Construcción de Cardioestimuladores del Uruguay (CCC) is dedicated to the development and manufacturing of complete real-time medical systems, including active implantable medical devices such as neuro & cardiac stimulators, programmer systems, battery chargers, patient wands and leads. CCC has over 35 years of experience in the medical devices field and are expanding activities to other safety-critical systems.

CONTACT: Investor Relations Contact: Elizabeth Cowell tel 214-618-4982 Media Contacts: Christopher Knospe tel 716-759-5727